Trends in childhood disease

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 608, Issue 2, 2006, Pages 100-111

  Pallapies, Dirk ^a  

^a BASF SE   (Germany)

Author keywords

Chemical exposure; Childhood cancer; Children's health; Developmental disease; Respiratory disease; Trend assessment

Indexed keywords

ALKYLATING AGENT; ANALGESIC AGENT; ANTIOXIDANT; DIETHYLSTILBESTROL; PROTEIN; VITAMIN;

ALCOHOL CONSUMPTION; ARTICLE; ASTHMA; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILD DEATH; CHILDHOOD CANCER; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLEAR CELL CARCINOMA; CRYPTORCHISM; DATA ANALYSIS; DEVELOPED COUNTRY; DEVELOPMENTAL DISORDER; DIAGNOSTIC TEST; DIARRHEA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EUROPE; GENITAL MALFORMATION; GEOGRAPHY; HUMAN; HYPOSPADIAS; LEARNING DISORDER; LEUKEMIA; LIFESTYLE; LYMPHOMA; MALARIA; MALE GENITAL SYSTEM; NERVE CELL DIFFERENTIATION; NEWBORN DISEASE; NUTRITION; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SIBLING; SMOKING; SOCIAL STATUS; TESTIS CANCER; UNITED KINGDOM; UNITED STATES; VAGINA CANCER;

ASTHMA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; CHILD MORTALITY; DEVELOPMENTAL DISABILITIES; ENVIRONMENTAL EXPOSURE; FEMALE; GENITALIA, MALE; HUMANS; LEARNING DISORDERS; MALE; NEOPLASMS; NERVOUS SYSTEM DISEASES; RESPIRATORY TRACT DISEASES;

NICOTIANA TABACUM;

EID: 33748374232     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2006.03.007     Document Type: Article

References (55)

1. Black R.E., Morris S.S., and Bryce J. Where and why are 10 million children dying every year?. Lancet 361 (2003) 2226-2234
2. Lawn J.E., Cousens S., and Zupan J. 4 million neonatal deaths: when? where? why?. Lancet 365 (2005) 891-900
3. ECETOC. Trends in children's health and the role of chemicals: state of the science review, Technical Report No. 96. European Centre for Ecotoxicology and Toxicology of Chemicals, Brussels, 2005.
4. World Health Organization (WHO). European Health for All Database (HFA-DB) and Supplementary European Health for All Mortality Database, 2003. (Available at: http://www.euro.who.int/hfadb).
5. Hartert T.V., and Peebles R.S. Epidemiology of asthma: the year in review. Curr. Opin. Pulm. Med. 6 (2000) 4-9
6. Beasley R., Crane J., Lai C.K.W., and Pearce N. Prevalence and etiology of asthma. J. Allergy Clin. Immunol. 105 (2000) 466-472
7. Johnson C.C., Ownby D.R., Zoratti E.M., Alford S.H., Williams L.K., and Joseph C.L.M. Environmental epidemiology of pediatric asthma and allergy. Epidemiol. Rev. 24 (2002) 154-175
8. O.S. von Ehrenstein. Asthma, allergies and respiratory health, in: G. Tamburlini, O. von Ehrenstein, R. Bertollini (Eds.), Children's Health and Environment: A Review of Evidence. Environmental Issue Report No. 29, EEA/WHO, 2002, pp. 44-65.
9. Ninan T.K., and Russel G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. Brit. Med. J. 304 (1992) 873-875
10. Omran M., and Russell G. Continuing increase in respiratory symptoms and atopy in Aberdeen schoolchildren. Brit. Med. J. 312 (1996) 34
11. Selnes A., Bolle R., Holt J., and Lund E. Cumulative incidence of asthma and allergy in north-Norwegian schoolchildren in 1985 and 1995. Pediatr. Allergy Immunol. 13 (2002) 58-63
12. http://www.statistics.gov.uk/cci/nugget.asp?id=722
13. Latvala J., von Hertzen L., and Haahtela T. Trends in prevalence of asthma and allergy in Finnish young men: nationwide study, 1999-2003. Brit. Med. J. 330 (2005) 1186-1187
14. ISAAC. Wordwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 351 (1998) 1225-1232
15. Sly R.M. Changing prevalence of allergic rhinitis and asthma. Ann. Allergy Asthma Immunol. 82 (1999) 233-248
16. Centers for Disease Control Prevention (CDC). Measuring childhood asthma prevalence before and after the 1997 redesign of the national health interview survey-United States. MMWR Weekly 49 (2000) 908-911
17. Eggleston P.A. Methods and effectiveness of indoor environmental control. Ann. Allergy Asthma Immunol. 87 Suppl. (2001) 44-47
18. US National Center for Health Statistics (US NCHS), Vital statistics of the United States, 1990, vol. II: mortality, part A, section 7, Technical Appendix, DHHS Publication No. (PHS)95-l 101, Public Health Service, Washington, DC, USA, 1994.
19. Sears M.R., Greene J.M., Willan A.R., Wiecek E.M., Taylor D.R., Flannery E.M., Cowan J.O., Herbison G.P., Silva P.A., and Poulton R. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N. Engl. J. Med. 349 (2003) 1414-1422
20. Woodruff T.J., Axelrad D.A., Kyle A.D., Nweke O., Miller G.G., and Hurley B.J. Trends in environmentally related childhood illnesses. Pediatrics 113 (2004) 1133-1140
21. Schettler T. Toxic threats to neurologic development of children. Environ. Health Perspect. 109 Suppl. 6 (2001) 813-816
22. NIMH. Attention Deficit Hyperactivity Disorder. National Institute of Health, National Institute of Mental Health, NIH Publication No. 3572 (available at: http://www.nimh.nih.gov/publicat/adhd.cfm).
23. American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Attention-deficit/Hyperactivity Disorder. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 105 (2000) 1158-1170
24. Fombonne E. The epidemiology of autism: a review. Psychol. Med. 29 (1999) 769-786
25. Newschaffer C.J., Fallin D., and Lee N.L. Heritable and nonheritable risk factors for autism spectrum disorders. Epidemiol. Rev. 24 (2002) 137-153
26. American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Attention-deficit/Hyperactivity Disorder, Committee on Children with Disabilities. The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics 107 (2001) 1221-1226
27. Gillberg C., and Soderstrom H. Learning disability. Lancet 362 (2003) 811-821
28. Barbaresi W.J., Katusic S.K., Colligan R.C., Weaver A.L., and Jacobsen S.J. The incidence of autism in Olmsted County, Minnesota, 1976-1997. Arch. Pediatr. Adolesc. Med. 159 (2005) 37-44
29. Dickens W.T., and Flynn J.R. Heritability estimates vs. large environmental effects: the IQ paradox resolved. Psychol. Rev. 108 (2001) 346-369
30. Aylward L.L., and Hays S.M. Temporal trends in human TCDD body burden: decreases over three decades and implications for exposure levels. J. Expo. Anal. Environ. Epidemiol. 12 (2002) 319-328
31. European Environment Agency/World Health Organization (EEA/WHO), G. Tamburlini, O.S. von Ehrenstein, R. Bertollini (Eds.), Children's Health and Environment: A Review of Evidence, Environmental Issue Report No. 29, Office for Official Publications of the European Communities, Luxembourg, 2002.
32. Dolk H., Vrijheid M., Scott J.E.S., Addor M.-C., Botting B., de Vigan C., de Walle H., Garne E., Loane M., Pierini A., Garcia-Minaur S., Physick N., Tenconi R., Wiesel A., Calzolari E., and Stone D. Towards the effective surveillance of hypospadias. Environ. Health Perspect. 112 (2004) 398-402
33. Aschim E.L., Haugen T.B., Tretli S., Daltveit A.K., and Grotmol T. Risk factors for hypospadias in Norwegian boys-association with testicular dysgenesis syndrome?. Int. J. Androl. 27 (2004) 213-221
34. Pierik F.H., Burdorf A., Deddens J.A., Juttmann R.E., and Weber R.F.A. Maternal and paternal risk factors for cryptorchidism and hypospadias: a case-control study in newborn boys. Environ. Health Perspect. 112 (2004) 1570-1576
35. Virtanen H.E., Kaleva M., Haavisto A.-M., Schmidt I.M., Chellakooty M., Main K.M., Skakkebæk N.E., and Toppari J. The birth rate of hypospadias in the Turku area in Finland. APMIS 109 (2001) 96-100
36. Boisen K.A., Kaleva M., Main K.M., Virtanen H.E., Haavisto A.-M., Schmidt I.M., Chellakooty M., Damgaard I.N., Mau C., Reunanen M., Skakkebaek N.E., and Toppari J. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363 (2004) 1264-1269
37. Kaleva M., Virtanen H.E., Haavisto A.-M., Main K.M., Reunanen M., Skakkebaek N.E., and Toppari J. Circannual rhythm in the incidence of cryptorchidism in Finland. Int. J. Androl. 28 (2005) 53-57
38. Pierik F.H., Burdorf A., de Muinck Keizer-Schrama S.M.P.F., Wolffenbuttel K.P., Rien Nijman J.M., Juttmann R.E., and Weber R.F.A. The cryptorchidism prevalence among infants in the general population of Rotterdam, the Netherlands. Int. J. Androl. 28 (2005) 248-252
39. van Gelderen H.H., and Vermeer-de Bondt P.E. Prevalence of undescended testis in the first 4 years of life: a longitudinal study. Ned. Tijdschr. Geneeskd. 130 (1986) 1567-1570
40. Linet M.S., Wacholder S., and Zahm S.H. Interpreting epidemiologic research: lessons from studies of childhood cancer. Pediatrics 112 (2003) 218-232
41. Steliarova-Foucher E., Stiller C., Kaatsch P., Berrino F., Coebergh J.W., Lacour B., and Parkin M. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet 364 (2004) 2097-2105
42. Kaatsch P., Haaf G., and Michaelis J. Childhood malignancies in Germany-methods and results of a nationwide registry. Eur. J. Cancer 31A (1995) 993-999
43. Dreifaldt A.C., Carlberg M., and Hardell L. Increasing incidence rates of childhood malignant diseases in Sweden during the period. Eur. J. Cancer 40 (2004) 1351-1360
44. Izquierdo J.N., and Schoenbach V.J. The potential and limitations of data from population-based state cancer registries. Am. J. Public Health 90 (2000) 695-698
45. L.A.G. Ries, M.A. Smith, J.G. Gurney, M. Linet, T. Tamra, J.L. Young, G.R. Bunin, Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program, NIH Publication No. 99-4649, Bethesda, MD, 1999.
46. Linet M.S., Ries L.A.G., Smith M.A., Tarone R.E., and Devesa S.S. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J. Nat. Cancer Institut. 91 (1999) 1051-1058
47. Smith M.A., Freidlin B., Gloeckler Ries L.A., and Simon R. Trends in reported incidence of primary malignant brain tumors in children in the United States. J. Nat. Cancer Institut. 90 (1998) 1269-1277
48. F. Valent, D. Little, R. Bertollini, L.E. Nemer, F. Barbone, G. Tamburlini, Burden of disease attributable to selected environmental factors and injury among children and adolescents in Europe, Lancet 363 (2004) 2032-2039. (Based on a WHO report available at: http://www.who.int/quantifying_ehimpacts/publications/9241591900/en/).
49. Altshuler K., Berg M., Frazier L.M., Laurenson J., Mendez W., and Molgaard C.A. OCHP Paper Series on Children's Health and the Environment: Overview of the Special Vulnerability and Health Problems of Children (2003), Office of Children's Health Protection at US Environmental Protection Agency, Washington, DC
50. Herbst A.L., Ulfelder H., and Poskanzer D.C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumour appearance in young women. N. Engl. J. Med. 284 (1971) 878-881
51. Strohsnitter W.C., Noller K.L., Hoover R.N., Robboy S.J., Palmer J.R., Titus-Ernstoff L., Kaufman R.H., Adam E., Herbst A.L., and Hatch E.E. Cancer risk in men exposed in utero to diethylstilbestrol. J. Nat. Cancer Institut. 93 (2001) 545-551
52. SCALE Baseline Report Technical Working Group on Endocrine Disruptors. http://www.environmentandhealth.org/twgim/twge/twge_documents.php.
53. Agency for Toxic Substances and Disease Registry (ATSDR), Pediatric Environmental Health Specialty Units (PEHSU), Atlanta, GA, 2005. (Available at: http://www.atsdr.cdc.gov).
54. Trasande L., and Landrigan P.J. The National Children's Study: a critical national investment. Environ. Health Perspect. 112 (2004) A789-A790
55. National Cancer Institute. Surveillance, epidemiology, and end results program, 1975-2000. Division of Cancer Control and Population Sciences (2003), National Cancer Institute, Bethesda, MD